Unituxin 3.5 mg (Dinutuximab SOLUTION) 3.5 MG

UNITUXIN 3.5 MG is a solution for intravenous administration, containing the active ingredient dinutuximab. This medication is used in specific therapeutic settings, often involving targeted treatment approaches. Learn more about its uses and effects.

Strength

3.5 MG

Pack Size

5ML

Manufacturer / TM Owner

UNITED THERAPEUTICS CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

UNITUXIN 3.5 MG is primarily used in targeted therapy protocols. It is often administered intravenously to support specific treatment plans. The medication is designed to interact with certain cellular mechanisms, making it a key component in some therapeutic regimens. What is UNITUXIN used for? It is typically utilized in settings where targeted intervention is required, often in conjunction with other treatments.

Side Effects

Common effects of UNITUXIN 3.5 MG may include reactions at the injection site, such as redness or swelling. Some individuals might experience systemic effects like fever or chills. These effects are generally monitored and managed by healthcare professionals during administration.

Precautions & Warnings

UNITUXIN 3.5 MG should be handled with care, following the guidelines provided by healthcare professionals. It is important to store the solution properly and administer it under controlled conditions. Patients should be monitored for any adverse reactions during and after administration.

Avoid Interactions

UNITUXIN 3.5 MG may interact with other medications, particularly those that affect the immune system or cellular mechanisms. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain foods might also influence the effectiveness or safety of the treatment.

Frequently Asked Questions

UNITUXIN 3.5 MG is used in targeted therapy protocols, often involving intravenous administration to support specific treatment plans.

UNITUXIN 3.5 MG is administered intravenously, typically under the supervision of healthcare professionals.

Common effects may include reactions at the injection site, such as redness or swelling, and systemic effects like fever or chills.

Yes, it should be handled with care, stored properly, and administered under controlled conditions. Patients should be monitored for any adverse reactions.

Yes, it may interact with other medications, particularly those affecting the immune system or cellular mechanisms. Always inform healthcare providers about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.